Use and Misuse of Aspirin in Primary Cardiovascular Prevention

Clinical Medicine Insights: Cardiology - New Zealand
doi 10.1177/1179546817702149
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Aspirin for Primary Prevention of Cardiovascular Events

Journal of General Internal Medicine
Internal Medicine
1998English

Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes Mellitus

Nature Reviews Endocrinology
EndocrinologyMetabolismDiabetes
2010English

Updated Meta-Analysis of Aspirin in Primary Prevention of Cardiovascular Disease

American Journal of Medicine
Medicine
2016English

Aspirin for Prevention of Cardiovascular Disease

Preventing chronic disease
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Aspirin for Prevention of Cardiovascular Disease

JAMA - Journal of the American Medical Association
Medicine
2020English

Aspirin Use and Cardiovascular Events in Social Networks

Social Science and Medicine
MedicinePhilosophy of ScienceHealthHistory
2012English

Aspirin Dose for the Prevention of Cardiovascular Disease

JAMA - Journal of the American Medical Association
Medicine
2007English

Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients: Results of the Primary Prevention Project (PPP) Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980–2009: The Minnesota Heart Survey

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy